Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

Specimen Handling 5Magnetic Resonance Spectroscopy 2Biopsy 2pembrolizumab 1dehydroftorafur 1atezolizumab 1Oxaliplatin 1Observation 1Nivolumab 1Naproxen 1Leucovorin 1Ipilimumab 1Fluorouracil 1Endoscopy 1Endoscopic Mucosal Resection 1Diffusion Tensor Imaging 1Colonoscopy 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Colorectal Neoplasms, Hereditary Nonpolyposis × Naproxen × Clear all
NCT02052908 2021-01-25

Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome

National Cancer Institute (NCI)

Phase 1 Completed
81 enrolled
Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡